Sunday, September 14, 2014 7:47:34 PM
UK LAUNCH OF CYTOSORB FROM CYTOSORBENTS
LINC Medical Systems Ltd is pleased to announce the UK launch of Cytosorb®, a powerful new weapon in the management of cytokine storm. The CytoSorb®filter will work with most standard hospital renal replacement therapy equipment and potentially increase survival rates in patients with high cytokine levels.
Cytokine storm is a major concern in the acute patient and can lead to multiple organ failure and death in many life threatening illnesses such as sepsis, septic shock, acute respiratory distress syndrome (ARDS), trauma and serious burn injury. CytoSorb®is the first-in-class therapy specifically CE approved as an extracorporeal cytokine filter in the European Union.
Its use is indicated where cytokines are elevated and can be used on most standard hospital renal replacement therapy equipment with uncomplicated set-up and easy use. Furthermore, CytoSorb®therapy is safe and well tolerated and performs without any serious device-related adverse incidents.
CytoSorb®has been shown to reduce cytokine storm in critical care illnesses and trial data indicates that patients treated with CytoSorb®:
- show improvement in respiratory function with fewer patients on mechanical ventilation at 28 days
- show a statistically significant reduction in 28 day all-cause mortality in a post-hoc analysis of a subgroup of patients with high cytokine levels
Mr Stephen Bailey, Managing Director of LINC Medical Systems, stated, "We are excited and privileged to bring CytoSorb® to the market in the UK and Ireland. By controlling cytokine storm and working to prevent or treat organ failure, CytoSorb® is a unique and innovative product that has the opportunity to transform the way critical care illnesses are managed. CytoSorb® treatment is simple to implement and leverages our own expertise in therapeutic blood purification. With few, if any, alternative treatments available, we expect a receptive and smooth introduction into the market." ??
Dr Christian Steiner, CytoSorbents' Vice President of Sales and Marketing, stated, "We are looking forward to working closely with LINC Medical Systems. Their significant experience in extracorporeal blood purification and their established network in critical care and nephrology make them an ideal partner to introduce CytoSorb® to intensive care units throughout the UK and Ireland. We plan to leverage our own key opinion leader relationships in the UK with those of LINC Medical to accelerate the sales and adoption process while working in parallel with LINC Medical to obtain reimbursement for CytoSorb® in these territories." ??
Recent CTSO News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:14:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:00:30 PM
- CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- CytoSorbents to Report First Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 04/26/2024 11:00:00 AM
- STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting • GlobeNewswire Inc. • 04/17/2024 11:00:00 AM
- CytoSorbents to Report Fiscal 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 10:20:45 PM
- Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients • GlobeNewswire Inc. • 01/17/2024 12:15:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/08/2024 08:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:49:02 PM
- CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation • GlobeNewswire Inc. • 12/28/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:35:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:33:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:31:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:30:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 02:15:22 PM
- CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering • GlobeNewswire Inc. • 12/13/2023 02:15:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/11/2023 09:10:44 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM